Columnist Shalom Lim will continue to pursue the themes that matter to him as a person with Duchenne MD, but as a writer now, ...

Agamree, an approved steroid treatment for Duchenne MD, will be sold in Turkey by GEN, per an agreement with Santhera.

Scientists have learned more about the structure of the collagen 6 protein and how muscular dystrophy-causing mutations affect it.

Preliminary data are expected this year for a Phase 1/2 clinical trial testing the investigational therapy SRP-1003 in DM1.

A protein called MYOD has long been known to be able to turn on genes, but a recent study has found that it also can turn off ...

Sevasemten is an oral small molecule being developed by Edgewise Therapeutics to prevent muscle damage in Duchenne muscular dystrophy.

In both good times and bad, the importance of human connection cannot be understated, columnist Patrick Moeschen writes.